Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
Public ClinicalTrials.gov record NCT00147654. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Placebo Controlled, Four Arm (Placebo, Tolterodine ER, Tamsulosin, and Tolterodine ER Plus Tamsulosin) Study To Evaluate The Clinical Efficacy And Safety Of Tolterodine ER 4 mg In Men Who Have Frequency and Urgency, With Or Without Urinary Urge Incontinence, With Or Without Bladder Outlet Obstruction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).
Study identification
- NCT ID
- NCT00147654
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 830 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- May 2006 (Actual)
- Last update posted
- Jan 27, 2021
2004 – 2006
United States locations
- U.S. sites
- 95
- U.S. states
- 31
- U.S. cities
- 95
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | — | — |
| Pfizer Investigational Site | Homewood | Alabama | — | — |
| Pfizer Investigational Site | Tucson | Arizona | — | — |
| Pfizer Investigational Site | Anaheim | California | — | — |
| Pfizer Investigational Site | Culver City | California | — | — |
| Pfizer Investigational Site | Fresno | California | — | — |
| Pfizer Investigational Site | La Mesa | California | — | — |
| Pfizer Investigational Site | Long Beach | California | — | — |
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | Murrieta | California | — | — |
| Pfizer Investigational Site | Poway | California | — | — |
| Pfizer Investigational Site | San Bernardino | California | — | — |
| Pfizer Investigational Site | Santa Monica | California | — | — |
| Pfizer Investigational Site | Aurora | Colorado | — | — |
| Pfizer Investigational Site | Boulder | Colorado | — | — |
| Pfizer Investigational Site | Denver | Colorado | — | — |
| Pfizer Investigational Site | New Britain | Connecticut | — | — |
| Pfizer Investigational Site | Waterbury | Connecticut | — | — |
| Pfizer Investigational Site | Melbourne | Florida | — | — |
| Pfizer Investigational Site | Ocala | Florida | — | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | — | — |
| Pfizer Investigational Site | Tallahassee | Florida | — | — |
| Pfizer Investigational Site | Wellington | Florida | — | — |
| Pfizer Investigational Site | Atlanta | Georgia | — | — |
| Pfizer Investigational Site | Columbus | Georgia | — | — |
| Pfizer Investigational Site | Roswell | Georgia | — | — |
| Pfizer Investigational Site | Melrose Park | Illinois | — | — |
| Pfizer Investigational Site | Evansville | Indiana | — | — |
| Pfizer Investigational Site | Jeffersonville | Indiana | — | — |
| Pfizer Investigational Site | Iowa City | Iowa | — | — |
| Pfizer Investigational Site | Overland Park | Kansas | — | — |
| Pfizer Investigational Site | Shreveport | Louisiana | — | — |
| Pfizer Investigational Site | Boston | Massachusetts | — | — |
| Pfizer Investigational Site | Brighton | Massachusetts | — | — |
| Pfizer Investigational Site | Watertown | Massachusetts | — | — |
| Pfizer Investigational Site | Columbia | Missouri | — | — |
| Pfizer Investigational Site | O'Fallon | Missouri | — | — |
| Pfizer Investigational Site | St Louis | Missouri | — | — |
| Pfizer Investigational Site | Missoula | Montana | — | — |
| Pfizer Investigational Site | Henderson | Nevada | — | — |
| Pfizer Investigational Site | Las Vegas | Nevada | — | — |
| Pfizer Investigational Site | Cherry Hill | New Jersey | — | — |
| Pfizer Investigational Site | Edison | New Jersey | — | — |
| Pfizer Investigational Site | Hamilton | New Jersey | — | — |
| Pfizer Investigational Site | Lawrenceville | New Jersey | — | — |
| Pfizer Investigational Site | Marlton | New Jersey | — | — |
| Pfizer Investigational Site | Mount Laurel | New Jersey | — | — |
| Pfizer Investigational Site | Sewell | New Jersey | — | — |
| Pfizer Investigational Site | Voorhees Township | New Jersey | — | — |
| Pfizer Investigational Site | Westhampton | New Jersey | — | — |
| Pfizer Investigational Site | Woodbury | New Jersey | — | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | — | — |
| Pfizer Investigational Site | Albany | New York | — | — |
| Pfizer Investigational Site | Bay Shore | New York | — | — |
| Pfizer Investigational Site | Carmel | New York | — | — |
| Pfizer Investigational Site | Cortlandt Manor | New York | — | — |
| Pfizer Investigational Site | Garden City | New York | — | — |
| Pfizer Investigational Site | Manhasset | New York | — | — |
| Pfizer Investigational Site | New York | New York | — | — |
| Pfizer Investigational Site | Orchard Park | New York | — | — |
| Pfizer Investigational Site | Poughkeepsie | New York | — | — |
| Pfizer Investigational Site | Staten Island | New York | — | — |
| Pfizer Investigational Site | Syracuse | New York | — | — |
| Pfizer Investigational Site | Cincinnati | Ohio | — | — |
| Pfizer Investigational Site | Cleveland | Ohio | — | — |
| Pfizer Investigational Site | Columbus | Ohio | — | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | — | — |
| Pfizer Investigational Site | Portland | Oregon | — | — |
| Pfizer Investigational Site | Allentown | Pennsylvania | — | — |
| Pfizer Investigational Site | Bala-Cynwyd | Pennsylvania | — | — |
| Pfizer Investigational Site | Bryn Mawr | Pennsylvania | — | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | — | — |
| Pfizer Investigational Site | State College | Pennsylvania | — | — |
| Pfizer Investigational Site | Wynnewood | Pennsylvania | — | — |
| Pfizer Investigational Site | Providence | Rhode Island | — | — |
| Pfizer Investigational Site | Charleston | South Carolina | — | — |
| Pfizer Investigational Site | Greenwood | South Carolina | — | — |
| Pfizer Investigational Site | Greer | South Carolina | — | — |
| Pfizer Investigational Site | Prosperity | South Carolina | — | — |
| Pfizer Investigational Site | Saluda | South Carolina | — | — |
| Pfizer Investigational Site | Germantown | Tennessee | — | — |
| Pfizer Investigational Site | Milan | Tennessee | — | — |
| Pfizer Investigational Site | Arlington | Texas | — | — |
| Pfizer Investigational Site | Austin | Texas | — | — |
| Pfizer Investigational Site | Houston | Texas | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Provo | Utah | — | — |
| Pfizer Investigational Site | Alexandria | Virginia | — | — |
| Pfizer Investigational Site | Arlington | Virginia | — | — |
| Pfizer Investigational Site | Charlottesville | Virginia | — | — |
| Pfizer Investigational Site | Fairfax | Virginia | — | — |
| Pfizer Investigational Site | Virginia Beach | Virginia | — | — |
| Pfizer Investigational Site | Spokane | Washington | — | — |
| Pfizer Investigational Site | Tacoma | Washington | — | — |
| Pfizer Investigational Site | Cheyenne | Wyoming | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00147654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 27, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00147654 live on ClinicalTrials.gov.